Cargando…

LNG-IUS treatment of non-atypical endometrial hyperplasia: Can Pipelle endometrial sampling be an accurate method of follow-up evaluation?

Detalles Bibliográficos
Autores principales:	Kim, Mi Kyoung, Seong, Seok Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644683/ https://www.ncbi.nlm.nih.gov/pubmed/23653824 http://dx.doi.org/10.3802/jgo.2013.24.2.103

Ejemplares similares

Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?
por: Dore, Molly, et al.
Publicado: (2021)

LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial
por: Abu Hashim, Hatem, et al.
Publicado: (2013)

The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia
por: Chen, Xiaojun
Publicado: (2019)

Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer
por: Terzic, Milan Milosav, et al.
Publicado: (2020)

Validity of pipelle endometrial sampling in patients with abnormal uterine bleeding
por: Fakhar, Shazia, et al.
Publicado: (2008)

Levonorgestrel-IUS system and endometrial manipulation
por: Malik, Sonia
Publicado: (2013)

Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method?
por: Kim, Mi Kyoung, et al.
Publicado: (2014)

Diagnostic Potential of Endometrial Cancer DNA from Pipelle, Pap-Brush, and Swab Sampling
por: Wang, Yinan, et al.
Publicado: (2023)

Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS
por: Bednarek, Paula H, et al.
Publicado: (2010)

miRNAs as Candidate Biomarker for the Accurate Detection of Atypical Endometrial Hyperplasia/Endometrial Intraepithelial Neoplasia
por: Giglio, Simona, et al.
Publicado: (2019)

Exploring the Role of Levonorgestrel Intrauterine System (LNG-IUS) as a Method of Emergency Contraception (EC)
por: Kumari, Snigdha, et al.
Publicado: (2022)

A controlled clinical trial comparing potent progestins, LNG‐IUS and dienogest, for the treatment of women with adenomyosis
por: Ota, Ikuko, et al.
Publicado: (2021)

Study of the Efficacy of Pipelle Biopsy Technique to Diagnose Endometrial Diseases in Abnormal Uterine Bleeding
por: Ilavarasi, C. Raja, et al.
Publicado: (2019)

Risk of atypical hyperplasia and endometrial carcinoma after initial diagnosis of non-atypical endometrial hyperplasia: A long-term follow-up study
por: Prip, Clara M., et al.
Publicado: (2022)

Pipelle endometrial biopsy for abnormal uterine bleeding: do patient’s pain and anxiety really impact on sampling success rate?
por: Kaiyrlykyzy, Aiym, et al.
Publicado: (2021)

A Global Learning Agenda for the Levonorgestrel Intrauterine System (LNG IUS): Addressing Challenges and Opportunities to Increase Access
por: Rademacher, Kate H., et al.
Publicado: (2018)

LNG-IUS vs. medical treatments for women with heavy menstrual bleeding: A systematic review and meta-analysis
por: Chen, Sijing, et al.
Publicado: (2022)

Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer
por: Holland, C M, et al.
Publicado: (2003)

Endometrial cancer arising from atypical complex hyperplasia: The significance in an endometrial biopsy and a diagnostic challenge
por: Byun, Jung Mi, et al.
Publicado: (2015)

Clinical Efficacy and Safety of Major Uterine Wall Resection and Reconstruction of the Uterus Combined with LNG-IUS for the Treatment of Severe Adenomyosis
por: Sun, Cui, et al.
Publicado: (2020)

Lymph node dissection in atypical endometrial hyperplasia
por: Taşkın, Salih, et al.
Publicado: (2017)

Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors
por: Giannella, Luca, et al.
Publicado: (2020)

PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study
por: Visser, Nicole C. M., et al.
Publicado: (2015)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
por: Chen, Junyu, et al.
Publicado: (2022)

Laparoscopic Surgery for Atypical Endometrial Hyperplasia with Awareness Regarding the Possibility of Endometrial Cancer
por: Kamii, Misato, et al.
Publicado: (2022)

Diagnostic Accuracy of Hysteroscopic Scoring System in Predicting Endometrial Malignancy and Atypical Endometrial Hyperplasia
por: Harika, Bhukya, et al.
Publicado: (2021)

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women
por: Uccella, Stefano, et al.
Publicado: (2022)

Value of endometrial thickness for the detection of endometrial cancer and atypical hyperplasia in asymptomatic postmenopausal women
por: Zhang, Linna, et al.
Publicado: (2022)

Pipelle Endometrial Biopsy for Abnormal Uterine Bleeding in Daily Clinical Practice: Why the Approach to Patients Should Be Personalized?
por: Tanko, Naanlep M., et al.
Publicado: (2021)

Microscale endometrial sampling biopsy in detecting endometrial cancer and atypical hyperplasia in a population of 1551 women: a comparative study with hysteroscopic endometrial biopsy
por: Zhang, Guo, et al.
Publicado: (2021)

Audit of waiting time‐to‐treatment of atypical endometrial hyperplasia
por: Anderson, Annabel, et al.
Publicado: (2022)

Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study
por: Kim, Mi Kyoung, et al.
Publicado: (2020)

Personalized treatment strategy for atypical endometrial hyperplasia with regards to age, comorbidities and endometrial receptor status
por: Goncharenko, Vadym M, et al.
Publicado: (2014)

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia
por: Matsuzaki, Toshiya, et al.
Publicado: (2018)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
por: Guan, Jun, et al.
Publicado: (2022)

Feasibility of RNA and DNA Extraction from Fresh Pipelle and Archival Endometrial Tissues for Use in Gene Expression and SNP Arrays
por: Kissel, Heather D., et al.
Publicado: (2013)

Massively parallel sequencing of endometrial lavage specimens for the detection of cancer-associated mutations in atypical and non-atypical endometrial hyperplasia
por: Weng, Cindy Hsuan, et al.
Publicado: (2022)

The PTEN, BAX, and IGFIIR Genes Are Mutated in Endometrial Atypical Hyperplasia
por: Yoshinaga, Kousuke, et al.
Publicado: (1998)

Simultaneous FTIR and Raman Spectroscopy in Endometrial Atypical Hyperplasia and Cancer
por: Barnas, Edyta, et al.
Publicado: (2020)

Use of a frameless LNG-IUS as conservative treatment for a pre-malignant uterine polyp in a premenopausal woman – a case report
por: Janssens, D, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jmhanntt7i8ahs9ar3gb23i59i